These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2498436

  • 1. Cytokines and pancreatic cancer. The effect of rIFN-gamma, HuLeIFN, rTNF-alpha, and LAK-cells on pancreatic and other gastrointestinal tumors in vitro.
    Kühl JS, Klapdor R, Mohr H, Arps H, Dietel M.
    Int J Pancreatol; 1989 Mar; 4(2):207-19. PubMed ID: 2498436
    [Abstract] [Full Text] [Related]

  • 2. Cytokines and pancreatic cancer. Sensitivity of xenotransplants of predominantly pancreatic carcinomas to rIFN-gamma and rTFN-alpha in nude mice.
    Kühl JS, Klapdor R, Bahlo M, Franke N, Kunde C, Arps H, Dietel M.
    Int J Pancreatol; 1989 Apr; 4(3):303-19. PubMed ID: 2503584
    [Abstract] [Full Text] [Related]

  • 3. Antineoplastic effects of tumor necrosis factor alone and in combination with gamma-interferon on tumor biopsies in clonogenic assay.
    Salmon SE, Young L, Scuderi P, Clark B.
    J Clin Oncol; 1987 Nov; 5(11):1816-21. PubMed ID: 3119787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude mice.
    Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Kawabata K, Masai Y, Tun T, Fukumoto M, Tobe T.
    Biotherapy; 1991 Nov; 3(4):337-44. PubMed ID: 1786197
    [Abstract] [Full Text] [Related]

  • 7. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
    Ruggiero V, Tavernier J, Fiers W, Baglioni C.
    J Immunol; 1986 Apr 01; 136(7):2445-50. PubMed ID: 3005411
    [Abstract] [Full Text] [Related]

  • 8. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
    Buscema M, Todd I, Deuss U, Hammond L, Mirakian R, Pujol-Borrell R, Bottazzo GF.
    J Clin Endocrinol Metab; 1989 Aug 01; 69(2):433-9. PubMed ID: 2502555
    [Abstract] [Full Text] [Related]

  • 9. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha.
    Brinchmann JE, Gaudernack G, Vartdal F.
    J Acquir Immune Defic Syndr (1988); 1991 Aug 01; 4(5):480-8. PubMed ID: 1673156
    [Abstract] [Full Text] [Related]

  • 10. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y, Koide Y, Kawabata M, Kitajima S, Ohba C, Suzuki H, Sekiguchi S.
    Exp Hematol; 1989 Aug 01; 17(7):795-9. PubMed ID: 2502422
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.
    Nio Y, Zighelboim J, Berek JS, Bonavida B.
    Cancer Immunol Immunother; 1988 Aug 01; 27(3):246-54. PubMed ID: 3180149
    [Abstract] [Full Text] [Related]

  • 12. Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations.
    Mortarini R, Belli F, Parmiani G, Anichini A.
    Int J Cancer; 1990 Feb 15; 45(2):334-41. PubMed ID: 1689276
    [Abstract] [Full Text] [Related]

  • 13. Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins.
    Safrit JT, Bonavida B.
    Cancer Immunol Immunother; 1992 Feb 15; 34(5):321-8. PubMed ID: 1540978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS, Scuderi P, Grimes WJ, Hersh EM.
    J Immunol; 1989 Mar 15; 142(6):2133-9. PubMed ID: 2493506
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of prolactin, rIFN-gamma or rTNF-alpha in murine toxoplasmosis.
    Benedetto N, Folgore A, Galdiero M, Meli R, Di Carlo R.
    Pathol Biol (Paris); 1995 May 15; 43(5):395-400. PubMed ID: 8532376
    [Abstract] [Full Text] [Related]

  • 19. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
    Beran M, Andersson BS, Kelleher P, Whalen K, McCredie K, Gutterman J.
    Blood; 1987 Mar 15; 69(3):721-6. PubMed ID: 3028534
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
    Bermudez LE, Young LS.
    J Immunol; 1988 May 01; 140(9):3006-13. PubMed ID: 2834450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.